News 13.05.2025 Schlieren (Zürich), Switzerland, May 13, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, is pleased to announce today’s Capital Markets Day on Tuesday, May 13, 2025, at 9am CEST, at the Hyatt Regency Zürich Airport, The Circle, Zürich, Switzerland. The event will also be...
News 08.05.2025 Lightium won the Prix Strategis 2025. The startup develops photonic chips for telecommunications and artificial intelligence. The Strategis Prize is awarded by HEC Espace Entreprise in Lausanne. Lightium, a start-up that specializes in photonic integrated circuits, won the Prix Strategis for the 32nd time this year. Based in the Bio-Technopark Schlieren-Zurich,...
News 07.05.2025 CUTISS has been granted a new patent in the United States for a core element of its automated platform used to manufacture personalized, bio-engineered human skin grafts. The patent (US Patent No. 12,286,611), titled “Tissue culture vessel for preparation of compressed hydrogel skin grafts and related methods and systems,” protects a...
News 27.04.2025 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced the...
News 17.04.2025 Zurich/Schlieren ZH - Researchers at the University of Zurich are developing a urine test for the diagnosis of prostate cancer. To advance the project and organize mass screening, they have founded the spin-off ONTRACK Biomedical. Biochemist Irina Banzola and urologist Daniel Eberli of the University of Zurich (UZH) have developed a...